Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bard secures Venetec

This article was originally published in The Gray Sheet

Executive Summary

CR Bard announces April 10 that it has completed its $166 mil. acquisition of StatLock securement technology manufacturer Venetec International. Bard has estimated that the move will result in an additional $18 mil. in 2006 revenue (1"The Gray Sheet" March 6, 2006, In Brief)...

You may also be interested in...



Bard buy

CR Bard signs $166 mil. agreement March 1 to acquire catheter securement technology firm Venetec International. Bard, with net sales of $1.77 bil. in 2005, estimates the deal will increase 2006 revenue growth by one percentage point over prior expectations, to 10%-11%, or by roughly $18 mil. The deal is expected to close in the second quarter. San Diego-based Venetec makes the StatLock line of molded gripping devices, which provide an alternative to tape or sutures for holding catheters in place. The items are used in catheter insertion kits and trays sold by Bard and other firms. Bard CEO Timothy Ring said the StatLock devices "fit very well strategically" with leading Bard products, including central venous and peripherally inserted central catheters and Foley and dialysis catheters...

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023432

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel